Introduction {#s1}
============

The human ether-a-go-go-related gene (hERG) encodes a potassium channel protein, which is important for cardiac electrical activity and the coordination of heartbeat. Blockade of the hERG potassium channel can result in a potentially fatal disorder called long QT syndrome, as well as serious cardiotoxicity, which has led to the withdrawal of several marketed drugs and the failure of many drug research and development projects ([@B19]; [@B60]; [@B64]; [@B6]; [@B50]; [@B89]; [@B67]; [@B33]; [@B48]). Therefore, drug candidates that can bind with hERG should be eliminated as early as possible in drug discovery studies. At present, various *in vitro* experimental assays, such as fluorescent measurements ([@B17]), radioligand binding assay ([@B88]), and patch-clamp electrophysiology ([@B70]; [@B21]; [@B13]), have been developed to measure the hERG binding affinity of chemicals. Nevertheless, these assays are often expensive and time-consuming, implying that they are not suitable for the evaluation of hERG binding affinity for a large number of chemicals in the early stage of drug discovery. Furthermore, the preconditions for the use of these analytical techniques are that the chemical compounds have been synthesized and are available in hand, which are usually not applicable in the era of virtual high-throughput screening. An alternative strategy is to use *in silico* methods; compared with experimental assays, *in silico* methods are cheaper and faster, and also do not involve any of the aforementioned preconditions.

To date, various *in silico* prediction models have been developed for hERG channel blockade. These models can be classified into structure-based and ligand-based models. Structure-based models utilize molecular docking to predict the binding mode and binding affinity of compounds to hERG. However, the structure-based methods often have some limitations such as protein flexibility, inaccurate scoring function, and solvent effect ([@B31]; [@B41]). Ligand-based models can further be classified into several categories based on structural and functional features ([@B92]; [@B3]), quantitative structure-activity relationship (QSAR) models ([@B54]; [@B87]; [@B73]), pharmacophore models ([@B10]; [@B4]; [@B18]; [@B84]; [@B36]; [@B78]), and machine learning models ([@B76]; [@B35]; [@B75]). Compared with other models, machine learning models have attracted more attention in recent years due to the remarkable performance of machine learning methods in the handling of classification issues. For example, [@B77] established binary classification models using Naïve Bayes (NB) classification and recursive partitioning (RP) methods, which achieved prediction accuracies of 85--89% in their test sets. Zhang and coworkers ([@B90]) used five machine learning methods to develop models that can discriminate hERG blockers from nonblockers, and they found that k-nearest neighbors (kNN) and support vector machine (SVM) methods showed a better performance than others. [@B7] derived several classification models of hERG blocker/nonblocker by using random forests (RF), SVM, and kNN algorithms with descriptor selections *via* genetic algorithm (GA) methods, and their prediction accuracies ranged from 83 to 86%. [@B15] employed a gradient-boosting machine (GBM) statistical technique to classify hERG blockers/nonblockers, and this offered overall prediction accuracies of 72--78% against different test sets. Very recently, [@B69] employed three methods (kNN, RF, and SVM) with different molecular descriptors, activity thresholds, and training set compositions to develop predictive models of hERG blockers/nonblockers, and their models showed better performance than previously reported ones.

There have been remarkable advances in deep learning methods since a fast learning algorithm for deep belief nets was proposed by Hinton in 2006 ([@B24]). They have widely been applied to fields particularly computer vision, speech recognition, natural language processing, audio recognition, social network filtering, machine translation, bioinformatics, and various games ([@B11]; [@B5]; [@B12]; [@B26]; [@B40]; [@B14]; [@B46]), where they have produced results comparable to or in some cases superior to human experts. In recent years, deep learning has also been applied to drug discovery, and it has demonstrated its potentials ([@B44]; [@B45]; [@B82]; [@B2]; [@B47]; [@B53]; [@B71]; [@B32]; [@B58]; [@B59]; [@B83]; [@B20]; [@B22]; [@B29]; [@B55]; [@B56]; [@B62]; [@B66]; [@B68]; [@B8]; [@B79]; [@B85]). However, there are still some issues that limit the application of deep learning in drug discovery. For example, deep learning usually requires a large number of samples for model training. Unfortunately, there are often a very limited number of agents (usually hundreds or thousands) in drug discovery-related studies due to high cost and the lengthy process involved in obtaining samples and their associated properties. In addition, commonly used deep learning algorithms or networks, such as convolutional neural network (CNN), are primarily designed for two-dimensional (2D) image recognition. In these networks, some special algorithms, such as the pooling algorithm in CNN, are adopted to reduce the dimensionality of the representation, which might lead to a loss of information.

To overcome the shortcomings of traditional deep learning networks, Hinton group ([@B63]) proposed new deep learning architectures known as capsule networks (CapsNets), which introduced a novel building block that is used in deep learning to improve the model hierarchical relationships inside the internal knowledge representation of a neural network. CapsNets have shown great potential in some fields ([@B81]; [@B1]; [@B38]; [@B57]; [@B74]; [@B91]; [@B79]; [@B52]). However, CapsNets have not yet been applied to drug discovery-related studies. As the first attempt, in this study, we established two classification models of hERG blockers/nonblockers by using modified capsule network architectures. The models were evaluated using a test set and an external validation set, which are independent of the training set. Furthermore, our models were also compared with others.

The rest of this paper is organized as follows. The *Materials and Methods* section describes the implementation of the two capsule networks \[convolution-capsule network (Conv-CapsNet) and RBM-CapsNet\] developed in this study, as well as the data sets used and computational modeling details. The modeling, evaluation, and comparison with other models are presented in the *Results* section. The strengths of the capsule networks are analyzed in the *Discussion* section which is followed by a final summary.

Materials and Methods {#s2}
=====================

Convolution-Capsule Network {#s2_1}
---------------------------

### Architecture {#s2_1_1}

The architecture of Conv-CapsNet is schematically shown in [**Figure 1**](#f1){ref-type="fig"}, which is similar in nature to that of the Hinton\'s original Capsule Network, except for one additional hidden feature layer. Apparently, Conv-CapsNet contains four layers: a convolutional layer, a hidden feature layer, a PrimaryCaps layer, and a DigitCaps layer. It is composed of 179 nodes for input, which are based on the feature vector size of the molecules. With mapping from the input vector, the hidden feature layer with 128 dimensional nodes was generated by one convolutional operation and one fully connected operation. The PrimaryCaps layer comprises eight capsules (*u~i~*), and each capsule in this layer includes eight-dimensional features. Furthermore, we computed the contribution (${\hat{u}}_{j|i}$) of each capsule (*u~i~*) in PrimaryCaps to that (*v~j~*) in DigitCaps by using Eq. 1.
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![Architecture of convolution-capsule networks (Conv-CapsNet). The input is one-dimensional vector containing 179 components. The convolution layer has 32 filters of size 1×3. The hidden feature layer and PrimaryCaps layer consist of 128 and 64 nodes, respectively. The weight matrix between PrimaryCaps layer and DigitCaps layer is 8×8×2×2, and two dynamic routing iterations were adopted.](fphar-10-01631-g001){#f1}

The final layer (DigitCaps) has a two-dimensional capsule ($v_{j}$) per digit class (two classes in this investigation). Each of these capsules received input from all the capsules in the PrimaryCaps layer through Eq. 2-1, Eq. 2-2, and Eq. 2-3.
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Finally, we computed the length of each digit capsule to predict the class of chemical molecules from Eq 3.
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In view of the small size of the dataset in this account, we added the L2 regularization behind the convolutional operation to prevent the network from overfitting ([@B51]).

### Hyperparameter Optimization {#s2_1_2}

For the hyperparameter optimization of the Conv-CapsNet architecture, the different numbers of filters in the convolutional layer, nodes in the hidden feature layer, and dimensions in PrimaryCaps were explored. Additionally, the dynamic routing iterations between two capsule layers were tested from 1 to 3 with an increment of 1. For each group of the parameter settings, the performance of the model was evaluated by five-fold cross-validation based on the training set. Once the highest accuracy was achieved with all the candidate settings, the best setting was subsequently applied to the test set and external validation set. We employed early stopping to reduce the overfitting problem, which is a technique commonly used for the reduction of overfitting ([@B9]). With the early stopping, original training set was randomly divided into a new training set and a validation set (4:1). When the error in the validation set was less than that from the previous iteration, the training was immediately stopped. The final optimal hyperparameters for Conv-CapsNet are listed in [**Table 1**](#T1){ref-type="table"}.

###### 

Hyperparameter settings of convolution-capsule networks (Conv-CapsNet).

  Hyperparameter                                Setting
  --------------------------------------------- ---------
  L2 normalization term                         0.001
  Activation                                    Relu
  Batch size                                    148
  Iteration epoch                               300
  Learning rate of network                      0.001
  Optimizer                                     Adam
  Filter                                        32
  Kernel_size                                   3
  Number of nodes in the hidden feature layer   128
  Number of nodes in the PrimaryCaps layer      64
  Routing time                                  2
  Dimension of each capsule                     8
  Length of PrimaryCaps                         2
  Length of DigitCaps                           2

### Model Training of Conv-CapsNet {#s2_1_3}

The Conv-CapsNet weights were randomly initialized using a truncated normal distribution with the standard deviation being set as 0.01 during training. Both the convolutional and hidden feature layers adopted the rectified linear unit (Relu) as the activation function. To reduce the internal-covariate-shift, we used batch normalization to normalize the input distribution of each layer to a standard Gaussian distribution ([@B25]; [@B30]). The adaptive moment estimation (Adam) method was employed for optimization ([@B34]).

[**Table 2**](#T2){ref-type="table"} summarizes the algorithm and training procedure for Conv-CapsNet. *CW*, *W*1, and *W*2 represent the parameters in the convolutional, hidden feature, and PrimaryCaps layers, respectively. The convolutional and the first two fully connected operations are represented by *conv*, *fc*1, and *fc*2, respectively; *conv_layer, hf_layer*, and *pc_layer* denote the output from the convolutional, hidden feature, and PrimaryCaps layers, respectively. Through a feature vector extraction process in the convolutional layer, the hidden feature layer, and the PrimaryCaps layer (lines 1--4), *pc_layer* was packed as capsules *u* (line 5). Here, $\hat{u}$ denotes the contribution of one layer to the next layer. Next, the routing algorithm was used to generate the digit capsules (lines 6--13). Len is the length of the output of DigitCaps layer (lines 14). Lines 15--20 are for the network parameter update using a gradient step.

###### 

Algorithm and training procedure of convolution-capsule networks (Conv-CapsNet).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  **Algorithm:** Conv-CapsNet training algorithm, using a mini-batch stochastic gradient descent (SGD) for simplicity.

  **Input:** mini batch feature vector **(*x*)**;\
     Number of Conv-CapsNet training epoch **(S)**;\
     Number of dynamic routing iterations **(iter)**.\
  **Output:** Length of each capsules **(Len)**.

  1:  **For** n=1 **to** S **do**\
  2:  *conv_layer* ← *conv*(*x*, *CW*)\
  3:  *hf_layer* ← *fc*1(*conv_layer*, *W*1)\
  4:  *pc_layer* ← *fc*2(*hf_layer*, *W*2)\
  5:  *u* ← Encapule(*pc_layer*)\
  6:  For all capsule *i* in PrimaryCaps layer:$\left. {\hat{u}}_{j|i}\leftarrow W_{ij}u_{i} \right.$............ {contribution computes Eq. 1}\
  7:  For all capsule *i* in PrimaryCaps layer and capsule *j* in DigitCaps layer:*b~ij~* ← 0\
  8:  **For** *m=1 to* **iter do**\
  9:   For all capsule *i* in PrimaryCaps layer: *c~i~* ← *softmax*(*b~i~*) ......{softmax computes Eq. 2-1}\
  10:  For all capsule *j* in DigitCaps layer:$\left. s_{j}\leftarrow\sum\limits_{i}c_{ij}{\hat{u}}_{j|i} \right.$ ...{dynamic computes Eq. 2-2}\
  11:  For all capsule *j* in DigitCaps layer: *v~j~* ← *squash* (*s~j~*) .........{squash computes Eq. 2-3}\
  12:  For all capsule *i* in PrimaryCaps layer and capsule *j* in DigitCaps layer:$\left. ~b_{ij}\leftarrow b_{ij} + {\hat{u}}_{j|i} \cdot v_{j} \right.$\
  13:  **End for**\
  14:  $\left. Len\leftarrow Length~of~v \right.$

  15:  $\left. L\leftarrow loss~of~v \right.$.............................................{loss computes Eq. 3}\
  16:  $\left. \ W\leftarrow W - \partial L/\partial W \right.$\
  17:  $\left. CW\leftarrow CW - \partial L/\partial CW \right.$\
  18: $\left. W1\leftarrow W1 - \partial L/\partial W1 \right.$\
  19:  $\left. W2\leftarrow W2 - \partial L/\partial W2 \right.$\
  20:  **End for**
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

Restricted Boltzmann Machine-Capsule Network {#s2_2}
--------------------------------------------

### Architecture {#s2_2_1}

[**Figure 2**](#f2){ref-type="fig"} displays the architecture of RBM-CapsNet, which consists of three layers: a hidden feature layer, a PrimaryCaps layer, and a DigitCaps layer. In RBM-CapsNet, two restricted Boltzmann machines (RBMs) replaced the convolutional and fully connected operations in Conv-CapsNet. The first RBM encodes the original vector (179-dimension) for the feature space (the hidden feature layer), which is subsequently used as the input for the next RBM. The RBMs used energy function (Eq. 4) as the loss function ([@B23]).
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![Architecture of restricted Boltzmann machine-capsule networks (RBM-CapsNet). The input is one-dimensional vector containing 179 components. The hidden feature layer and PrimaryCaps layer consist of 256 and 128 nodes, respectively. The weight matrix between PrimaryCaps layer and DigitCaps layer is 8×8×2×2, and two dynamic routing iterations were adopted.](fphar-10-01631-g002){#f2}

The capsule networks still consist of PrimaryCaps and DigitCaps, which are the same as in Conv-CapsNet. The detailed definitions of all the parameters in Eq. 1, 2, 3, and 4 are listed in the [**Supplementary Material**](#SM1){ref-type="supplementary-material"}.

### Hyperparameter Optimization {#s2_2_2}

To optimize the hyperparameters in the RBM-CapsNet architecture, all the combinations of one to five RBM operations and 32, 64, 128, 256, and 512 nodes in each RBM were tested. The basic optimization procedure for the hyperparameters related to the capsules is very similar with that for Conv-CapsNet. The performance of each RBM-CapsNet architecture was examined by five-fold cross-validation. The candidate RBM-CapsNet architecture that provided the highest accuracy was validated using the test set and external validation set. The detailed information on the optimized hyperparameters in RBM-CapsNet is summarized in [**Table 3**](#T3){ref-type="table"}.

###### 

Hyperparameter settings of restricted Boltzmann machine-capsule networks (RBM-CapsNet).

  Hyperparameter                                Setting
  --------------------------------------------- ---------
  Numbers of RBM                                2
  Number of nodes in the hidden feature layer   256
  Number of nodes in the PrimaryCaps layer      128
  Iteration of RBM                              100
  Iteration of network                          200
  Learning rate of RBM                          0.001
  Learning rate of network                      0.005
  Activation                                    Relu
  Batch size                                    148
  Optimizer                                     Adam
  Routing time                                  2
  Dimension of each capsule                     8
  Length of PrimaryCaps                         2
  Length of DigitCaps                           2

### Model Training of Restricted Boltzmann Machine-Capsule Network {#s2_2_3}

The training process was divided into two stages. First, two RBMs were pre-trained one by one with the loss function shown in Eq. 4. Second, the parameters of RBMs from pre-training were taken as initial values and the whole network was fine-tuned by back-propagation algorithm with end-to-end ([@B61]).

[**Table 4**](#T4){ref-type="table"} summarizes the algorithm and training procedure for RBM-CapsNet. *θ*1 and *θ*2 represent the parameters of the hidden feature and PrimaryCaps layers, respectively. *ϕ*1 and *ϕ*2 represent the operations in RBM1 and RBM2, respectively. The *hf_layer* and *pc_layer* denote the output from the hidden feature and PrimaryCaps layers, respectively. After training RBM1 and RBM2 individually (lines 1--6), the *pc_layer* was packed as capsules *u* (line 10). The routing algorithm was then used to generate the digit capsules (lines 11--18). Len is the length of the output of DigitCaps layer (lines 19). Lines 20 to 24 are for a network parameter update using a gradient step (∂*L/*∂*W* represents the gradient of the contribution matrix, and ∂*L/*∂*θ*1 and ∂*L/*∂*θ*2 represent the gradients of the parameters for the hidden feature and PrimaryCaps layers, respectively).

###### 

Algorithm and training procedure of restricted Boltzmann machine-capsule networks (RBM-CapsNet).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Algorithm:** RBM-CapsNet training algorithm, using a mini-batch stochastic gradient descent (SGD) for simplicity.

  **Input:** mini batch feature vector **(*x*)**;\
     Number of RBM training epoch **(S1)**;\
     Number of Capsule training epoch **(S2)**;\
     Number of dynamic routing iterations **(iter)**.\
  **Output:** Length of each capsules **(Len).**

  1:  **For** n=1 **to** S1 **do**\
  2:  $\left. hf\_ layer\leftarrow\phi 1\left( {x,\theta 1} \right) \right.$.............................................{RBM1 training}\
  3:  **End for**\
  4:  **For** n=1 **to** S1 **do**\
  5:  $\left. pc\_ layer\leftarrow\phi 2\left( {hf\_ layer,\theta 2} \right) \right.$.......................................{RBM2 training}\
  6:  **End for**

  7:  **For** n=1 **to** S2 **do**\
  8:  $\left. hf\_ layer\leftarrow\phi 1\left( {x,\theta 1} \right) \right.$\
  9:  $\left. pc\_ layer\leftarrow\phi 2\left( {h1\_ layer,\theta 2} \right) \right.$\
  10:  $\left. u\leftarrow\text{Encapule~}\left( {pc\_ layer\ } \right) \right.$\
  11:   For all capsule *i* in PrimaryCaps layer:$\left. {\hat{u}}_{j|i}\leftarrow W_{ij}u_{i} \right.$............{contribution computes Eq. 1}\
  12:  For all capsule *i* in PrimaryCaps layer and capsule *j* in DigitCaps layer:$\left. b_{ij}\leftarrow 0 \right.$\
  13:  **For** *m=1 to* **iter do**\
  14:  For all capsule *i* in PrimaryCaps layer: ......{softmax computes Eq. 2-1}\
  15:  For all capsule *j* in DigitCaps layer:$\left. ~s_{j}\leftarrow~\sum\limits_{i}c_{ij}{\hat{u}}_{j|i} \right.$.........{dynamic computes Eq. 2-2}\
  16:  For all capsule *j* in DigitCaps layer:$\left. v_{j}\leftarrow squash\left( s_{j} \right) \right.$............{squash computes Eq. 2-3}\
  17:  For all capsule *i* in PrimaryCaps layer and capsule *j* in DigitCaps layer: $\left. ~b_{ij}\leftarrow b_{ij} + {\hat{u}}_{j|i} \cdot v_{j} \right.$\
  18:  **End for**

  19:  $\left. Len\leftarrow Length~of~v \right.$\
  20:  $\left. L\leftarrow loss~of~v \right.$.............................................{loss computes Eq. 3}\
  21: $\left. W\leftarrow W - \partial L/\partial W \right.$\
  22: $\left. \theta 1\leftarrow\theta 1 - \partial L/\partial\theta 1 \right.$\
  23: $\left. \theta 2\leftarrow\theta 2 - \partial L/\partial\theta 2 \right.$\
  24: **End for**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

Data Sets {#s2_3}
---------

In this investigation, the Doddareddy\'s hERG blockade data set was used to establish our models ([@B16]), which includes literature compounds tested on the hERG channel and Food and Drug Administration (FDA)-approved drugs. This data set contains a total of 2,644 compounds, including 1,112 positives (hERG blocker, IC~50~ \< 10 μM) and 1,532 negatives (hERG nonblocker, IC~50~ \> 30 μM). Doddareddy et al. partitioned this data set into a training set and a test set ([@B16]). For comparison, the same partition scheme for the training and test sets as that by Doddareddy et al. was adopted in this investigation. Furthermore, we used Doddareddy\'s experimentally validated dataset (a total of 60 compounds: 50 agents from the Chembridge database and 10 from an in-house compound library) as an external validation set to assess the generalization ability of our models. In order to compare the performance of our models with others reported in the literature, we also used the same data sets as those in the literature, including Hou\'s ([@B77]; [@B78]), Zhang\'s ([@B90]), Sun\'s ([@B72]), Siramshetty\'s ([@B69]), and Cai\'s ([@B8]) data sets. Here, it is necessary to mention that an integrated data set of hERG blockade, which is the largest database to date, has been collected by [@B65]. However, we did not use this data set because it was not accessible. Another reason was that this data set has not been used to develop prediction models so far, and hence, a comparison study involving the data set was not feasible.

Molecular Characterization {#s2_4}
--------------------------

In this investigation, a combination of MACCS (MDL Molecular Access) molecular fingerprints (166 bits) and 13 molecular descriptors was utilized to characterize the chemical compounds, which has been used by Zhang et al. and showed a good predictive performance in hERG blockade classification modeling ([@B90]). Another reason why we adopted this characterization method (MACCS+13 descriptors, a total of 179 features) is because of their short length which is important for the reduction of the number of parameters in the modeling and the training time. By the way, the 13 molecular descriptors were selected because they are thought to be very related to ADMET properties and have been widely used in the modeling of various ADMET properties ([@B27]; [@B28]; [@B77]; [@B90]). A detailed list of these descriptors are given as follows: the octanol-water partitioning coefficient, apparent partition coefficient at pH = 7.4, molecular solubility, molecular weight, number of hydrogen bond donors, number of hydrogen bond acceptors, number of rotatable bonds, number of rings, number of aromatic rings, sum of the oxygen and nitrogen atoms, polar surface area, molecular fractional polar surface area, and molecular surface area.

All the molecular fingerprints and molecular descriptors were computed with RDKit ([@B39]) and PaDEL-Descriptor ([@B86]), respectively. Because the values of the different descriptors might span significantly different numerical ranges, their values were scaled to the same range (0, 1) by using the following formula:
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Model Assessment {#s2_5}
----------------

All the models were assessed based on their accuracy (Q), sensitivity (SE), and specificity (SP). Q reflects the total prediction effect of a classifier. SE and SP represent the predictive power for positives and negatives, respectively. The definitions are given as follows (TP, true positive/blocker; TN, true negative/nonblocker; FP, false positive/blocker; and FN, false negative/nonblocker):
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The classification capability of models was measured by area under the receive operating characteristic curve (AUC), which is an important indicator to illustrate the classification performance by changing its discrimination threshold.

Another measurement of the quality of binary (two-class) classifications is the Matthew\'s correlation coefficient (MCC). The MCC considers the balance ratios of the four confusion matrix categories (TP, TN, FP, and FN), and reflects the predictive power of models objectively without the influence of the disproportionate ratio of positives to negatives in the dataset. The MCC was calculated by using the following equation:
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Computations {#s2_6}
------------

All the calculations were carried out with a single dual-processor, 16-core 2.1 GHz Intel® Xeon® E5-2683 v4 CPU with 126 GB memory and two NVIDIA Tesla P100 GPU accelerators. The software modules that were used to implement this project included Scikit-learn 0.18.1, Python 3.6.4, Anaconda 5.1.0 (64-bit), and TensorFlow 1.4.0.

Results {#s3}
=======

Selection of the Optimal Capsule Network Architectures and Model Development {#s3_1}
----------------------------------------------------------------------------

Hinton et al raised the concept of capsule network and proposed the first capsule network architecture prototype ([@B63]). To find the optimal capsule network architectures for the modeling of hERG blockade, we tried to construct a number of capsule networks with different architectures following Hinton\'s principle. Here, the Doddareddy\'s training set (positives: 1,004; negatives: 1,385) was adopted to train all the models, and the five-fold cross-validation method was used to monitor the training processes. In the five-fold cross-validation, the training set was randomly divided into five subsets. Of the five subsets, four subsets were used as the training data, and the remaining subset was used as the validation data for testing the model. The cross-validation process was repeated five times, with each of the five subsets used exactly once as the validation data. The average of the results from the five runs was calculated to produce a single estimation. The five-fold cross-validation results for the training set are given in [**Table 5**](#T5){ref-type="table"}. According to these results, Conv-CapsNet and RBM-CapsNet showed the best performance. For the Conv-CapsNet model, the prediction accuracies for the hERG blockers (SE) and the hERG nonblockers (SP) were 88.6 and 89.1%, respectively, and the overall prediction accuracy (Q) was 88.9%. For the RBM-CapsNet model, the prediction accuracies for hERG blockers and nonblockers were 84.3 and 89%, respectively and the overall prediction accuracy was 87.0%. Importantly, the MCC values of Conv-CapsNet and RBM-CapsNet were 0.774 and 0.734, respectively, which were also the highest among all the MCC values ([**Table 5**](#T5){ref-type="table"}); a higher MCC value often indicates a better prediction power of model. Therefore, the architectures of Conv-CapsNet and RBM-CapsNet were chosen as our capsule network architectures, and a detailed description for these architectures was given in the *Materials and Methods* section.

###### 

Prediction results of hERG blockers/nonblockers classification models developed by capsule networks with different architectures.

  Capsule network architecture    SE          SP          MCC         SD           Q (%)
  ------------------------------- ----------- ----------- ----------- ------------ -----------
  Original CapsNet                80.4%       86.7%       0.673       0.0141       84.1%
  FC+FC                           82.6%       86.7%       0.694       0.0195       85.0%
  Conv+FC                         82.2%       86.4%       0.687       0.0166       84.6%
  Conv+FC+FC **(Conv-CapsNet)**   **88.6%**   **89.1%**   **0.774**   **0.0109**   **88.9%**
  Conv+Conv+FC+FC                 84.5%       85.3%       0.693       0.0142       84.9%
  Conv+Conv+Conv+FC+FC            81.9%       86.9%       0.685       0.0173       84.9%
  One RBM                         83.1%       86.5%       0.694       0.0182       84.9%
  Two RBMs **(RBM-CapsNet)**      **84.3%**   **89.0%**   **0.734**   **0.0160**   **87.0%**
  Three RBMs                      84.5%       85.5%       0.696       0.0160       85.0%
  Four RBMs                       81.2%       86.0%       0.673       0.0108       83.9%
  Five RBMs                       84.1%       86.4%       0.701       0.0156       85.4%

\*Conv, convolutional operation; FC, fully connected operation; RBM, restricted Boltzmann machine; Conv-CapsNet, convolution-capsule network; RBM-CapsNet, restricted Boltzmann machine-capsule network (The training set used was the Doddareddy\'s training set, and five-fold cross-validation was used to monitor the training performance. SE (%), sensitivity; SP (%), specificity; MCC, Matthew\'s correlation coefficient; SD, standard deviation; Q (%), overall accuracy). Conv-CapsNet and Conv-CapsNet showed the best performance.

Validation of Our Models' Prediction Ability Against hERG Blockers/Nonblockers by Doddareddy's Test Set and External Validation Set {#s3_2}
-----------------------------------------------------------------------------------------------------------------------------------

In the above subsection, we obtained the optimal architectures of capsule networks. With these capsule network architectures, two classification models of hERG blockers/nonblockers, Conv-CapsNet and RBM-CapsNet models have been developed. To verify the predictive ability of these models, two test sets that are independent of the training set were used: Doddareddy\'s test set (positives: 108; negatives: 147) and external validation set (positives: 18; negatives: 42).

[**Table 6**](#T6){ref-type="table"} summarizes the prediction results of the Conv-CapsNet and RBM-CapsNet models. From [**Table 6**](#T6){ref-type="table"}, we can see that both models show excellent prediction ability to the Doddareddy\'s test set and external validation set. With the Conv-CapsNet model, of the 108 blockers in the test set, 102 were correctly predicted, indicating a prediction accuracy of 94.4% for the blockers (SE). For the 147 nonblockers, 132 (TN) were properly predicted. The accuracy for the prediction of nonblockers (SP) was 89.8%. Of all the 255 agents (blockers and nonblockers), 234 were correctly predicted and 20 were wrongly predicted (see [**Table 6**](#T6){ref-type="table"}). The overall prediction accuracy (Q) and AUC measure were 91.8% and 0.940 (see [**Figure 3**](#f3){ref-type="fig"}), respectively. For the external validation set, of the 18 blockers, 16 (TP) were correctly discriminated from nonblockers. The prediction accuracy for the blockers (SE) was 88.9%. Of the 42 nonblockers, 30 (TN) were correctly predicted, indicating a prediction accuracy of 71.4% for the nonblockers (SP). Totally, 46 out of 60 compounds were correctly predicted. The overall prediction accuracy (Q) and AUC measure were 76.7% and 0.806, respectively. With the RBM-CapsNet model, in the test set, 99 (TP) out of 108 blockers were correctly predicted, indicating a prediction accuracy of 91.7%. Out of 147 nonblockers, 136 (TN) were correctly predicted, indicating a prediction accuracy of 92.5% for nonblockers. This model achieved an overall prediction accuracy of 92.2%. For the external validation set, the prediction accuracies for blockers (SE) and nonblockers (SP) were 94.4 and 71.4%, respectively. The overall prediction accuracy (Q) and the MCC values were 78.7% and 0.604, respectively. AUC for the test and external validation sets were 0.944 (see [**Figure 3**](#f3){ref-type="fig"}) and 0.811, respectively. All of these results clearly demonstrate that the established Conv-CapsNet and RBM-CapsNet models can not only correctly classify the training set compounds but also have an outstanding predictability for external agents outside of the training set.

###### 

Prediction accuracies of hERG blockade classification models developed by different methods with the same Doddareddy\'s training set.

  Model                                               SE      SP      MCC     Q (%)   AUC
  --------------------------------------------------- ------- ------- ------- ------- -------
  Doddareddy\'s test set (255/P:108, N:147)                                           
  Conv-CapsNet                                        94.4%   89.8%   0.835   91.8%   0.940
  RBM-CapsNet                                         91.7%   92.5%   0.840   92.2%   0.944
  CNN                                                 87.0%   85.0%   0.715   85.9%   0.933
  MLP                                                 82.4%   86.4%   0.687   84.7%   0.920
  DBN                                                 72.2%   80.8%   0.533   80.8%   0.903
  SVM                                                 90.7%   84.4%   0.743   87.1%   0.933
  kNN                                                 69.4%   96.6%   0.703   85.1%   0.928
  Logistic regression                                 88.8%   83.7%   0.710   85.5%   0.858
  LightGBM                                            79.6%   82.3%   0.617   81.2%   0.810
  Doddareddy\'s external validation (60/P:18, N:42)                                   
  Conv-CapsNet                                        88.9%   71.4%   0.554   76.7%   0.806
  RBM-CapsNet                                         94.4%   71.4%   0.604   78.7%   0.811
  CNN                                                 94.4%   52.4%   0.441   65.0%   0.725
  MLP                                                 88.9%   57.1%   0.426   66.7%   0.707
  DBN                                                 88.9%   52.4%   0.386   63.3%   0.683
  SVM                                                 88.9%   52.4%   0.386   63.3%   0.660
  kNN                                                 77.8%   52.4%   0.279   60.0%   0.624
  Logistic regression                                 83.3%   52.4%   0.332   61.7%   0.623
  LightGBM                                            61.1%   59.5%   0.190   60.0%   0.609

(TP, true positive; TN, true negative; FP, false positive; FN, false negative; SE (%), sensitivity, SE = TP/(TP + FN); SP (%), specificity, SP = TN/(TN + FP); Q (%), overall accuracy, Q = \[TP + TN)/(TP + TN + FP + FN)\].

![Receiver operating characteristic (ROC) curves for Doddareddy\'s test set by **(A)** convolution-capsule networks (Conv-CapsNet) and **(B)** restricted Boltzmann machine-capsule networks (RBM-CapsNet), respectively.](fphar-10-01631-g003){#f3}

Comparison of Our Models With Other Models Developed With the Same Doddareddy's Training Set {#s3_3}
--------------------------------------------------------------------------------------------

To compare the performance of our models with that of others, we adopted commonly used machine learning methods to develop prediction models of hERG blockers/nonblockers with the same Doddareddy\'s training set. These machine learning methods include deep belief network (DBN), CNN, multilayer perceptron (MLP), SVM, kNN, logistic regression (LR), and LightGBM. Hyperparameters for these methods were optimized by five-fold cross-validation in advance, and the optimal hyperparameter values are listed in [**Tables S1--S4**](#SM1){ref-type="supplementary-material"}, respectively. The prediction results to the Doddareddy\'s test set and external validation set are also given in [**Table 6**](#T6){ref-type="table"}. From [**Table 6**](#T6){ref-type="table"}, we can see that the prediction accuracies of the seven models are obviously lower than those of our Conv-CapsNet and RBM-CapsNet models.

Comparison of Our Models With Other Models Developed With Training Sets Different From Doddareddy's Training Set {#s3_4}
----------------------------------------------------------------------------------------------------------------

It has been well known that the performance of a prediction model is often strongly dependent on the training set used. Therefore, to make a more objective comparison, we collected various hERG blockade classification models developed with training sets different from Doddareddy\'s training set. With these training sets, we established a series of new prediction models by the Conv-CapsNet and RBM-CapsNet methods. To avoid a possible influence of molecular features, the same molecular features used in the literature were used. [**Table 7**](#T7){ref-type="table"} summarizes the prediction accuracies of various models reported in the literature together with those of models by Conv-CapsNet and RBM-CapsNet.

###### 

Prediction results of various hERG blockade classification models developed with training sets different from Doddareddy\'s training set.

  Entry          Model               Training set                                        Test set                                  SE      SP      Q
  -------------- ------------------- --------------------------------------------------- ----------------------------------------- ------- ------- -------
  1              RP ([@B78])         Hou\'s training set 1 (P: 283; N: 109)              Hou\'s test set 1 (P: 129; N: 66)         79.8%   75.8%   78.5%
  NB ([@B78])    82.2%               75.8%                                               80.0%                                                     
  SVM ([@B78])   90.7%               65.2%                                               82.1%                                                     
  Conv-CapsNet   85.7%               78.8%                                               82.0%                                                     
  RBM-CapsNet    84.1%               80.3%                                               82.0%                                                     
  2              RP ([@B78])         Hou\'s training set 2 (P: 272; N: 120)              Hou\'s test set 2 (P: 140; N: 55)         80.0%   74.5%   78.5%
  NB ([@B78])    81.4%               80.0%                                               81.0%                                                     
  SVM ([@B78])   85.0%               74.5%                                               82.1%                                                     
  Conv-CapsNet   82.1%               81.8%                                               82.0%                                                     
  RBM-CapsNet    81.4%               83.6%                                               82.0%                                                     
  3              Bayesian ([@B77])   Hou\'s training set 3 (P: 314; N: 306)              Hou\'s test set 3 (P: 63; N: 57)          86.9%   83.1%   85.0%
  Conv-CapsNet   87.3%               86.0%                                               86.8%                                                     
  RBM-CapsNet    88.9%               84.2%                                               86.8%                                                     
  4              SVM ([@B90])        Zhang\'s training set (P: 717; N: 210)              Zhang\'s test set (P: 188; N: 48)         95.8%   34.0%   83.5%
  kNN ([@B90])   92.6%               40.4%                                               82.2%                                                     
  Conv-CapsNet   88.8%               66.7%                                               84.5%                                                     
  RBM-CapsNet    90.4%               64.6%                                               85.2%                                                     
  5              LibSVM ([@B69])     Sun\'s training set (P: 483; N: 2541)               Sun\'s test set (P: 53; N: 13)            68.0%   85.0%   71.0%
  RF ([@B69])    72.0%               85.0%                                               74.0%                                                     
  Conv-CapsNet   83.0%               84.6%                                               83.3%                                                     
  RBM-CapsNet    86.8%               84.6%                                               86.3%                                                     
  6              LibSVM ([@B69])     Siramshetty\'s training set T3 (P: 1406; N: 1708)   Doddareddy\'s test set (P: 108; N: 147)   64.0%   89.0%   78.0%
  RF ([@B69])    68.0%               91.0%                                               81.0%                                                     
  Conv-CapsNet   85.2%               88.4%                                               87.1%                                                     
  RBM-CapsNet    83.3%               91.2%                                               87.8%                                                     

Entry 1--3 of [**Table 7**](#T7){ref-type="table"} list models developed with Hou\'s training set 1 (positives: 283; negatives: 109), training set 2 (positives: 272; negatives: 120), and training set 3 (positive: 314; negative: 306), respectively. In Hou\'s training sets 1 and 2, a threshold of 40 µM was used to distinguish hERG blockers and nonblockers (blockers: IC~50~ \< 40 µM; nonblockers: IC~50~ ≥ 40 µM). With training sets 1 and 2, Hou et al. established three models by RP, NB, and SVM methods, and the SVM models showed the best performance on their test sets. In Hou\'s training set 3, a threshold of 30 µM was used to define hERG blockers and nonblockers. A Bayesian classification model developed by Hou et al. with Hou\'s training set 3 gave a prediction accuracy of 85% on their test set. With Hou\'s training sets 1--3, we also separately established models by Conv-CapsNet and RBM-CapsNet methods. As shown in [**Table 7**](#T7){ref-type="table"}, our models showed comparable or superior performance compared with Hou\'s models. Entry 4 in [**Table 7**](#T7){ref-type="table"} shows models established by Zhang\'s training set (positives: 717; negatives: 210), in which a threshold of 30 µM was used to define hERG blockers and nonblockers. With the training set, Zhang et al. built two models by using SVM and kNN methods, which gave prediction accuracies of 83.5 and 82.2%, respectively, on their test set. Our models, developed by Conv-CapsNet and RBM-CapsNet, exhibited a better performance on the same test set (prediction accuracies: 84.5 and 85.2%, respectively). Entry 5 in [**Table 7**](#T7){ref-type="table"} displays models developed with Sun\'s training set, which is a big data set consisting of 3,024 agents (positives: 483; negatives: 2,541) with a threshold of 30 µM for defining hERG blockers and nonblockers. With the training set, Siramshetty et al. established two models by using LibSVM and RF methods, and their prediction accuracies on the test set were 71.0 and 74.0%, respectively. Our models offered much higher prediction accuracies (Conv-CapsNet: 83.3%; RBM-CapsNet: 86.3%). Entry 6 in [**Table 7**](#T7){ref-type="table"} shows models built with Siramshetty\'s training set T3 which were extracted from the ChEMBL database. In this training set, agents with a binding affinity of less than 1 µM were defined as hERG blockers, and those with a binding affinity of greater than 10 µM were defined as hERG nonblockers. With the training set, Siramshetty et al. established two models by using LibSVM and RF methods, and their prediction accuracies on their test set were 78.0 and 81.0%, respectively. Our Conv-CapsNet and RBM-CapsNet models gave prediction accuracies of 87.1 and 87.8%, respectively, which are obviously higher than those of LibSVM and RF models. Very recently, Cai et al. developed a deep learning model, termed deephERG, to predict hERG blockers with a large dataset containing 7,889 compounds ([@B8]). To make a comparison, we also used the same datasets to train and test hERG blocker prediction models. With the same validation set and evaluation method as those in Cai\'s work, our Conv-CapsNet (AUC = 0.974) and RBM-CapsNet (AUC = 0.978) showed a better performance than their deephERG (AUC = 0.967) (see [**Table S5**](#SM1){ref-type="supplementary-material"}). Collectively, for different training sets given here, the models developed by Conv-CapsNet and RBM-CapsNet were among the best models established by various machine learning methods.

Discussion {#s4}
==========

Since the first capsule networks were proposed by Hinton\'s group in 2017 ([@B63]), they have attracted considerable attention because of their performance. For example, despite the simple three-layer architecture of the original capsule networks, they have achieved state-of-the-art results with 0.25% test error on Mixed National Institute of Standards and Technology database (MNIST) without data augmentation, which is better than the previous baseline of 0.39% ([@B63]). The excellent performance of capsule networks is mainly due to the introduction of the capsules and dynamic routing algorithms. A capsule is a set of neurons that forms a vector. These vectors contain information including the magnitude/prevalence, spatial orientation, and other attributes of the extracted feature. In the capsule networks, capsules are "routed" to any capsule in the next layer *via* a dynamic routing algorithm, which takes into account the agreement between these capsule vectors, thus forming meaningful part-to-whole relationships not found in standard CNNs. In other words, capsule networks are capable of catching and holding more fine information than traditional deep neuron networks, one benefit of which is that the amount of input data can be significantly reduced.

Although CapsNets were just proposed very recently, they have already been successfully applied in many fields ([@B1]; [@B37]; [@B38]; [@B42]; [@B43]; [@B49]; [@B57]; [@B91]; [@B52]). Among these applications, majorities are related to image recognition. For example, [@B1] established a CapsNet for brain tumor classification by recognizing brain magnetic resonance imaging (MRI) images and proved that it could successfully overcome the defects of CNNs. [@B37] proposed a novel method for traffic sign detection using a CapsNet that achieved outstanding performance, the input of which was traffic sign images. [@B42] built a CapsNet to recognize rice composites from unmanned aerial vehicle (UAV) images. This is understandable because CapsNets were originally developed to overcome the defects associated with image recognition in the traditional deep learning networks.

In image recognition, the input data is a two-dimensional array. In this two-dimensional array data, adjacent data points are often highly correlated. Small changes in any points generally do not affect image recognition in traditional deep learning methods. However, in issues related to drug discovery, such as the evaluation of ADMET properties (like the prediction of hERG blockers), one-dimensional vectors that describe small molecular structures and properties are usually used as the network input, for example, molecular fingerprints and descriptors. Generally, there is no direct logical relationship between the components in each vector for this kind of input. Importantly small changes in vector components might have a significant impact on the entire molecular structure and its associated properties. Nevertheless, these small changes in vector components are often overlooked in traditional deep learning methods. In addition, the relative positions of vector components are often critical though there is no direct logical relationship between them because a vector component represents a substructure or property. In this situation, capsule networks, which adopt vector neurons, are expected to have a better performance in handling this kind of issue (like the hERG blocker modeling) than other deep scalar neuron networks.

As expected, the two established capsule networks, Conv-CapsNet and RBM-CapsNet, showed excellent performance in the classification of hERG blockade. Although this is the first application of capsule networks in the classification of hERG blockers/nonblockers, the established models are still among the best classification models for hERG blockers/nonblockers. There can be no doubt that the use of capsules or vector neurons is one of the main reasons that contribute to the excellent performance of our models. Here each capsule represents a combination of substructures and/or properties. Analogy to the case in image recognition, the length of each capsule is the probability that the combination of substructures or properties exists in a molecule, and the orientation may represent the relative position of the combination of substructures in a compound. Obviously, our capsule networks can learn some combinations of substructures and/or properties that are important for the hERG blockers or nonblockers. Even so, we have to acknowledge that the prediction models of hERG blockers/nonblockers developed by the new capsule networks are still like a black box. Some questions regarding the models are difficult to answer. For example, we can\'t exactly know what the combination of substructures and/or properties is, and which features are important to the model and which samples are hard to classify. Overall, the application of capsule networks in drug discovery is still in its infancy. Further improvement of capsule networks and applications in drug discovery are necessary in future studies.
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